skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Anthracycline extravasation injuries: management with dexrazoxane

Review

(2439) Views  (943) Full article downloads

Authors: Karin Jordan, Timo Behlendorf, Franziska Mueller, Hans-Joachim Schmoll

Published Date May 2009 Volume 2009:5 Pages 361 - 366
DOI: http://dx.doi.org/10.2147/TCRM.S3694

Karin Jordan, Timo Behlendorf, Franziska Mueller, Hans-Joachim Schmoll

Clinic for Internal Medicine IV, Department for Oncology and Haematology, University Hospital Halle, Halle, Germany

Abstract: The application of anthracyclines in anticancer therapy may result in accidental extravasation injury and can be a serious complication of their use. Tissue necrosis with skin ulceration is a possible outcome in the inadvertent extravasation of anthracyclines during intravenous administration. Until recently, there has been no effective treatment against the devastating effect of extravasated anthracycline. Preclinical and clinical studies are leading to the clinical implementation of dexrazoxane as the first and only proven antidote in anthracycline extravasation. In two multicenter studies dexrazoxane has proven to be highly effective in preventing skin necrosis and ulceration. This review focuses on the development and management of dexrazoxane in anthracycline extravasation injuries.

Keywords: dexrazoxane, extravasation, necrosis, anthracyclines








Readers of this article also read:

Management of glucocorticoids-induced osteoporosis: role of teriparatide
Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
The benefits and risks of testosterone replacement therapy: a review
An update on the management of acne vulgaris
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Optimizing supercritical antisolvent process parameters to minimize the particle size of paracetamol nanoencapsulated in L-polylactide
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy